Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Gates, Milner Back Cancer-Genetics Startup

Jan. 8 (Bloomberg) -- Microsoft Corp. co-founder Bill Gates and Russian billionaire Yuri Milner invested in genetics startup Foundation Medicine Inc., joining prior backers including Google Ventures and Kleiner Perkins Caufield & Byers.

Gates and Milner helped Foundation raise an additional $13.5 million in an expansion of its Series B financing, bringing the total raised in the round to $56 million, the Cambridge, Massachusetts-based company said today in a statement. Evan Jones, co-founder of Digene Corp., participated in the financing and will join Foundation’s board.

Foundation makes tools that can inspect DNA to determine individuals’ risk of cancer and help doctors make treatment decisions.

Link to Company News:{18453Z US <Equity> CN <GO>} Link to Company News:{892139Z RU <Equity> CN <GO>} Link to Company News:{MSFT US <Equity> CN <GO>} Link to Company News:{QGEN US <Equity> CN <GO>} Link to Company News:{ZZISK US <Equity> CN <GO>} Link to Company News:{PEF2736 RU <Equity> CN <GO>} Link to Company News:{45982Z US <Equity> CN <GO>}

To contact the reporter on this story: Lisa Rapaport in New York at lrapaport1@bloomberg.net

To contact the editor responsible for this story: Lisa Rapaport at lrapaport1@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.